Hydrochloric Acid

Hydrochloric Acid

SCHEMBL7168696

[BH4-].[Ce+3].[Cl-].[Cl-].[Cl-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113493430-A Intermediate of beraprost and salt thereof and preparation method thereof 上海时莱生物技术有限公司 2021-10-12 CN disclosed
US-6555559-B1 Prostaglandin I2 (PGI2); use as an anti-Helicobacter agent, a platelet function potentiating agent or a cervical ripening agent; side effect reduction TORAY INDUSTRIES, INC. (JP) 2003-04-29 US disclosed
EP-1044972-A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME TORAY INDUSTRIES, INC. (JP) 2000-10-18 EP disclosed
EP-0710233-B1 HETEROARYL CYCLOALKENYL HYDROXYUREAS PFIZER (US) 1999-10-13 EP disclosed
EP-0790981-B1 ARYLOXYCYCLOALKENYL AND ARYLOXYIMINOCYCLOALKENYLHYDROXYUREAS AS 5-LIPOXYGENASE INHIBITORS PFIZER (US) 1999-09-08 EP disclosed
US-5798383-A Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas PFIZER INC. (US) 1998-08-25 US disclosed
US-5792882-A Phenoxyphenyl cyclopentenyl hydroxyureas PFIZER INC. (US) 1998-08-11 US disclosed
US-5665768-A Heteroaryl cycloalkenyl hydroxyureas PFIZER INC. (US) 1997-09-09 US disclosed
EP-0790981-A1 ARYLOXYCYCLOALKENYL AND ARYLOXYIMINOCYCLOALKENYLHYDROXYUREAS AS 5-LIPOXYGENASE INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1997-08-27 EP disclosed
EP-0736006-A1 PHENYLTHIOPHENYL CYCLOALKENYL HYDROXYUREAS AS LIPOXYGENASE INHIBITORS PFIZER INC. (US) 1996-10-09 EP disclosed
EP-0720598-A1 PHENOXYPHENYL CYCLOPENTENYL HYDROXYUREAS PFIZER INC. (US) 1996-07-10 EP disclosed
WO-1996016054-A1 CYCLOALKENYL-N-HYDROXYUREAS PFIZER PHARMACEUTICALS INC. (JP) 1996-05-30 WO disclosed
WO-1996015106-A1 ARYLOXYCYCLOALKENYL AND ARYLOXYIMINOCYCLOALKENYLHYDROXYUREAS AS 5-LIPOXYGENASE INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1996-05-23 WO disclosed
EP-0710233-A1 HETEROARYL CYCLOALKENYL HYDROXYUREAS PFIZER INC. (US) 1996-05-08 EP disclosed
WO-1995017379-A1 PHENYLTHIOPHENYL CYCLOALKENYL HYDROXYUREAS AS LIPOXYGENASE INHIBITORS PFIZER INC. (US) 1995-06-29 WO disclosed
WO-1995005360-A1 PHENOXYPHENYL CYCLOPENTENYL HYDROXYUREAS PFIZER INC. (US) 1995-02-23 WO disclosed
WO-1995003292-A1 HETEROARYL CYCLOALKENYL HYDROXYUREAS PFIZER INC. (US) 1995-02-02 WO disclosed